The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
01 2023
Historique:
revised: 25 07 2022
received: 06 04 2022
accepted: 25 08 2022
pubmed: 30 8 2022
medline: 11 1 2023
entrez: 29 8 2022
Statut: ppublish

Résumé

The nature and dynamics of mutations associated with the emergence, spread, and vanishing of SARS-CoV-2 variants causing successive waves are complex. We determined the kinetics of the most common French variant ("Marseille-4") for 10 months since its onset in July 2020. Here, we analyzed and classified into subvariants and lineages 7453 genomes obtained by next-generation sequencing. We identified two subvariants, Marseille-4A, which contains 22 different lineages of at least 50 genomes, and Marseille-4B. Their average lifetime was 4.1 ± 1.4 months, during which 4.1 ± 2.6 mutations accumulated. Growth rate was 0.079 ± 0.045, varying from 0.010 to 0.173. Most of the lineages exhibited a bell-shaped distribution. Several beneficial mutations at unpredicted sites initiated a new outbreak, while the accumulation of other mutations resulted in more viral heterogenicity, increased diversity and vanishing of the lineages. Marseille-4B emerged when the other Marseille-4 lineages vanished. Its ORF8 gene was knocked out by a stop codon, as reported in SARS-CoV-2 of mink and in the Alpha variant. This subvariant was associated with increased hospitalization and death rates, suggesting that ORF8 is a nonvirulence gene. We speculate that the observed heterogenicity of a lineage may predict the end of the outbreak.

Identifiants

pubmed: 36031728
doi: 10.1002/jmv.28102
pmc: PMC9539255
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28102

Informations de copyright

© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Lemey P, Ruktanonchai N, Hong SL, et al. Untangling introductions and persistence in COVID-19 resurgence in Europe. Nature. 2021;595:713-717.
Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600:408-418.
Vöhringer HS, Sanderson T, Sinnott M, et al. Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature. 2021;600:506-511.
Rochman ND, Wolf YI, Faure G, Mutz P, Zhang F, Koonin EV. Ongoing global and regional adaptive evolution of SARS-CoV-2. Proc Natl Acad Sci USA. 2021;118:e2104241118.
Colson P, Fournier P-E, Chaudet H, et al. Analysis of SARS-CoV-2 variants from 24,181 patients exemplifies the role of globalisation and zoonosis in pandemics. Front Microbiol. 2022;12:786233.
Tomaszewski T, DeVries RS, Dong M, et al. New pathways of mutational change in SARS-CoV-2 proteomes involve regions of intrinsic disorder important for virus replication and release. Evol Bioinform Online. 2020;16:1176934320965149.
Hay JA, Kennedy-Shaffer L, Kanjilal S, et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science. 2021;373:eabh0635.
Omer SB, Yildirim I, Forman HP. Herd immunity and implications for SARS-CoV-2 control. JAMA. 2020;324:2095-2096.
Palese P, Wang TT. Why do influenza virus subtypes die out? A hypothesis. mBio. 2011;2:e00150-11.
Pegu A, O'connell SE, Schmidt SD, et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021;373:1372-1377.
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-534. doi:10.1016/S1473-3099(20)30120-1
Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall. 2017;1:33-46.
Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6:3773.
Rambaut A, Holmes EC, O'toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403-1407.
Fournier PE, Colson P, Levasseur A, et al. Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4' variant. Int J Infect Dis. 2021;106:228-236.
Colson P, Levasseur A, Delerce J, et al. Dramatic increase in the SARS-CoV-2 mutation rate and low mortality rate during the second epidemic in summer in Marseille. IHU Preprints. 2020. https://www.mediterranee-infection.com/dramatic-increase-in-the-sars-cov-2-mutation-rate-and-low-mortality-rate-during-the-second-epidemic-in-summer-in-marseille/. doi:10.35088/68c3-ew82
Hodcroft E. CoVariants: SARS-CoV-2 mutations and variants of interest; 2021. Available from https://covariants.org/
Hodcroft EB, Zuber M, Nadeau S, et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595:707-712.
Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911-919.
Prates ET, Garvin MR, Pavicic M, et al. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2. Mol Biol Evol. 2021;38:702-715.
Pereira F. SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin. Gene. 2021;784:145596.
Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18:2714-2723.
Froimowitz M. 1HyperChem: a software package for computational chemistry and molecular modeling. Biotechniques. 1993;14:1010-1013.
Fantini J, Yahi N, Azzaz F, Chahinian H. Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks. J Infect. 2021;83:197-206.
Flower TG, Buffalo CZ, Hooy RM, Allaire M, Ren X, Hurley JH. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc Natl Acad Sci USA. 2021;118:e2021785118.
Elena SF, Miralles R, Cuevas JM, Turner PE, Moya A. The two faces of mutation: extinction and adaptation in RNA viruses. IUBMB Life. 2000;49:5-9.
Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol. 1997;51:151-178.
Domingo E. Virus as Population. 1st ed. Elsevier, Academic Press; 2016:1-412.
van Dorp L, Richard D, Tan CCS, Shaw LP, Acman M, Balloux F. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020;11:5986.
Miralles R, Gerrish PJ, Moya A, Elena SF. Clonal interference and the evolution of RNA viruses. Science. 1999;285:1745-1747.
Muller HJ. The relation of recombination to mutational advance. Mutat Res. 1964;106:2-9.
Elena SF, Moya A. Rate of deleterious mutation and the distribution of its effects on fitness in vesicular stomatitis virus. J Evol Biol. 1999;12:1078-1088.
Nemudryi A, Nemudraia A, Wiegand T, et al. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. Cell Rep. 2021;35:109197.
Zinzula L. Lost in deletion: the enigmatic ORF8 protein of SARS-CoV-2. Biochem Biophys Res Commun. 2021;538:116-124.
Velazquez-Salinas L, Zarate S, Eberl S, Gladue DP, Novella I, Borca MV. Positive selection of ORF1ab, ORF3a, and ORF8 genes drives the early evolutionary trends of SARS-CoV-2 during the 2020 COVID-19 pandemic. Front Microbiol. 2020;11:550674.
Lo Presti A, Rezza G, Stefanelli P. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction. Heliyon. 2020;6:e05001.
Cheng L, Han X, Zhu Z, Qi C, Wang P, Zhang X. Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2. Brief Bioinform. 2021;22:1442-1450.
Lau SK, Feng Y, Chen H, et al. Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-Related coronavirus from greater horseshoe bats through recombination. J Virol. 2015;89:10532-10547.
Georgiades K, Merhej V, El Karkouri K, Raoult D, Pontarotti P. Gene gain and loss events in rickettsia and orientia species. Biol Direct. 2011;6:6.
Maurelli AT. Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens. FEMS Microbiol Lett. 2007;267:1-8.
Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303:1666-1669.
Moran NA. Microbial minimalism: genome reduction in bacterial pathogens. Cell. 2002;108:583-586.
Corman VM, Baldwin HJ, Tateno AF, et al. Evidence for an ancestral association of human coronavirus 229E with bats. J Virol. 2015;89:11858-11870.
Valcarcel A, Bensussen A, Álvarez-Buylla ER, Díaz J. Structural analysis of SARS-CoV-2 ORF8 protein: pathogenic and therapeutic implications. Front Genet. 2021;12:693227.
Senkevich TG, Yutin N, Wolf YI, Koonin EV, Moss B. Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus-host interaction genes. mBio. 2021;12:e0149521.
Van Valen L. A new evolutionary law. Evol Theory. 1973;1:1-30.
Hachim A, Kavian N, Cohen CA, et al. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020;21:1293-1301.
Wang X, Lam JY, Chen L, et al. Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients. Emerg Microbes Infect. 2021;10:1016-1023.
Amrane S, Tissot-Dupont H, Doudier B, et al. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, -January 31st to March 1st, 2020: a respiratory virus snapshot. Travel Med Infect Dis. 2020;36:101632.
Bedotto M, Fournier PE, Houhamdi L, et al. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant. J Clin Virol. 2021;139:104814.
Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094-3100.
Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078-2079.
Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. arXiv. 2012;arXiv:1207.3907.
Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121-4123.
Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004;32:W526-W531.
Di Scala C, Fantini J. Hybrid in silico/In vitro approaches for the identification of functional cholesterol-binding domains in membrane proteins. Methods Mol Biol. 2017;1583:7-19.
Chen J, Gupta AK. Parametric Statistical Change Point Analysis with Applications to Genetics, Medicine, and Finance. 2nd ed. Birkhauser; 2012.
White R, Vynnycky E. An Introduction to Infectious Disease Modelling. OUP Oxford; 2016.
Zhao S, Tang B, Musa SS, et al. Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data. Epidemics. 2021;36:100482.
Byrne AW, McEvoy D, Collins AB, et al. Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open. 2020;10:e039856.

Auteurs

Philippe Colson (P)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Philippe Gautret (P)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Vecteurs-Infections Tropicales et Méditerranéennes (VITROME), Aix-Marseille University, Marseille, France.

Jeremy Delerce (J)

IHU Méditerranée Infection, Marseille, France.

Hervé Chaudet (H)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement (IRD), Vecteurs-Infections Tropicales et Méditerranéennes (VITROME), Aix-Marseille University, Marseille, France.
French Armed Forces Center for Epidemiology and Public Health (CESPA), Camp de Sainte Marthe, Marseille, France.

Pierre Pontarotti (P)

IHU Méditerranée Infection, Marseille, France.
Centre national de la recherche scientifique (CNRS), Marseille, France.

Patrick Forterre (P)

Département de Microbiologie, Institut Pasteur, Paris, France.
Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette, France.

Raphael Tola (R)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.

Marielle Bedotto (M)

IHU Méditerranée Infection, Marseille, France.

Léa Delorme (L)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement (IRD), Vecteurs-Infections Tropicales et Méditerranéennes (VITROME), Aix-Marseille University, Marseille, France.
French Armed Forces Center for Epidemiology and Public Health (CESPA), Camp de Sainte Marthe, Marseille, France.

Wahiba Bader (W)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Anthony Levasseur (A)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Jean-Christophe Lagier (JC)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Matthieu Million (M)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Nouara Yahi (N)

INSERM UMR_S 1072, Aix-Marseille Université, Marseille, France.

Jacques Fantini (J)

INSERM UMR_S 1072, Aix-Marseille Université, Marseille, France.

Bernard La Scola (B)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Pierre-Edouard Fournier (PE)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Didier Raoult (D)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH